Trevena, Inc. (OTC:TRVN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Terrance McGuire Other companies: Tectonic Therapeutic, Inc. (Director · Since at least Jun 20, 2024); Invivyd, Inc. (Director · Since at least Aug 5, 2021); Seer, Inc. (Director · Since at least Dec 3, 2020); Cyclerion Therapeutics, Inc. (Director · Apr 1, 2019 – Nov 30, 2023 · Past); Alector, Inc. (Director · Feb 6, 2019 – Sep 11, 2023 · Past); X4 Pharmaceuticals, Inc. (Director · Nov 15, 2017 – Jun 5, 2018 · Past); Pulmatrix, Inc. (Director · Jun 15, 2015 – May 16, 2019 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Mar 2, 2017 · Past); Ironwood Pharmaceuticals, Inc. (Director · Jun 3, 2013 – Apr 1, 2019 · Past) | Director · Jan 30, 2014 – May 14, 2014 · Past |
| François Nader Other companies: Tectonic Therapeutic, Inc. (Chair, Board of Directors · Since at least Feb 23, 2026); Moderna, Inc. (Director · Since at least Dec 10, 2019); Tourmaline Bio Inc. (Director · May 6, 2021 – Jun 13, 2023 · Past); Prevail Therapeutics Inc (Director · Jun 19, 2019 – Jan 22, 2021 · Past); Alexion Pharmaceuticals Inc (Director · Nov 15, 2017 – Jul 21, 2021 · Past); Baxalta Inc (Director · Jul 27, 2015 – Jun 3, 2016 · Past); Acceleron Pharma Inc (Director · Dec 11, 2014 – Nov 19, 2021 · Past); NPS Pharmaceuticals Inc (President, CEO and Director, Director · Apr 8, 2013 – Feb 21, 2015 · Past) | Director · Jan 30, 2014 – May 20, 2015 · Past |
| Mark Corrigan Other companies: Wave Life Sciences Ltd. (Director · Since at least Sep 4, 2019); Novelion Therapeutics Inc (Director · Mar 30, 2017 – Aug 9, 2018 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Aug 2, 2022 · Past); CoLucid Pharmaceuticals Inc (Director · Oct 27, 2015 – Mar 1, 2017 · Past); Avanir Pharmaceuticals Inc (Director · Mar 18, 2014 – Mar 18, 2014 · Past); EPIRUS Biopharmaceuticals Inc (Director · Dec 21, 2009 – Jun 5, 2015 · Past); Cubist Pharmaceuticals Inc (Director · Jun 20, 2008 – Jan 21, 2015 · Past); Sepracor Inc (Executive VP, R&D · Mar 16, 2006 – Oct 20, 2009 · Past) | Director · Jul 18, 2023 – Jun 13, 2024 · Past |
| Jonathan Violin Other companies: Cyclerion Therapeutics, Inc. (Chief Executive Officer · Since at least Apr 1, 2026); Crescent Biopharma, Inc. (Director · Since at least Jun 13, 2025); Dianthus Therapeutics, Inc. (Director · Since at least Sep 11, 2023); Astria Therapeutics Inc (Director · Since at least Jan 28, 2021); Viridian Therapeutics, Inc. (Chief Executive Officer, Director · Oct 27, 2020 – Feb 2, 2023 · Past) | SVP-Scientific Affairs & IR · Jan 29, 2018 – Feb 28, 2018 · Past |
| Maxine Gowen Other companies: Passage Bio, Inc. (Chairwoman · Since at least Feb 18, 2021); Aclaris Therapeutics, Inc. (Director · Since at least Jul 2, 2019); Aceragen Inc. (Director · Jan 4, 2015 – Aug 10, 2023 · Past); Akebia Therapeutics, Inc. (Director · Jul 28, 2014 – Jun 5, 2020 · Past); Human Genome Sciences Inc (Director · Feb 15, 2008 – Jul 30, 2012 · Past) | Director · Since at least Jan 30, 2014 |
| Anne Phillips Other companies: Sagimet Biosciences Inc. - Series A (Board Member · Since at least Aug 1, 2024); vTv Therapeutics Inc. (Director · Since at least Mar 13, 2024); Vaccitech plc (Director · Apr 29, 2021 – May 11, 2023 · Past); AMAG Pharmaceuticals Inc (Director · Apr 10, 2019 – Nov 16, 2020 · Past) | Member of Nominating and Corporate Governance Committee · Since at least Dec 16, 2014 |
| Farah Champsi Other companies: Population Health Investment Co Inc (Director · Nov 17, 2020 – Jan 26, 2021 · Past); Kite Pharma Inc (Director · Jun 19, 2014 – Oct 3, 2017 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – May 28, 2013 · Past); Chimerix Inc (Director · Apr 10, 2013 – Oct 23, 2013 · Past) | Director · Jan 30, 2014 – Dec 10, 2014 · Past |
| Julie McHugh Other companies: Lantheus Holdings, Inc. (Director · Since at least Jan 25, 2017); Ironwood Pharmaceuticals, Inc. (Chair, Biopharmaceutical Industry Executive, Retired · Since at least Jun 1, 2016); Evelo Biosciences, Inc. (Director · Apr 9, 2021 – Jun 8, 2023 · Past); Aerie Pharmaceuticals Inc. (Director · Jun 8, 2016 – Nov 21, 2022 · Past) | Chair of the Nominating and Corporate Governance Committee · Since at least May 18, 2016 |
| Leon O Moulder Jr Other companies: Zenas BioPharma, Inc. (See Remarks, Director · Since at least Sep 12, 2024); Zai Lab Ltd. (Director · Since at least Jan 1, 2021); Dianthus Therapeutics, Inc. (Director · Sep 11, 2023 – May 23, 2024 · Past); Tesaro Inc (Chief Executive Officer, Director · Mar 1, 2018 – Jan 22, 2019 · Past) | Director · May 16, 2018 – Jun 15, 2023 · Past |
| Jason Raleigh Nunn Other companies: Addex Therapeutics Ltd (Director · Since at least Mar 18, 2026); Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Regulus Therapeutics Inc (Director · Since at least Jun 6, 2019) | Director · May 16, 2019 – Jun 13, 2024 · Past |
| David F Solomon Other companies: Clinical Data Inc (Vice President, Director · Apr 13, 2011 – Apr 13, 2011 · Past); Forest Laboratories Inc (SVP-CorpDev/Strategic Planning · Dec 8, 2008 – Dec 6, 2013 · Past) | Director · Jan 30, 2014 – May 14, 2014 · Past |
| John P. Hamill Other companies: Aprea Therapeutics, Inc. (Senior Vice President and Chief Financial Officer · Since at least Jan 30, 2023); Windtree Therapeutics, Inc. (SVP & CFO · Jul 20, 2020 – Jul 26, 2022 · Past) | VP Fin,Princ Fin&Acct Officer · May 31, 2019 – May 31, 2019 · Past |
| Barry Shin Other companies: Compass Therapeutics, Inc. (Chief Financial Officer · Since at least Dec 9, 2024) | Acting COO and CFO · Jun 25, 2019 – Oct 8, 2024 · Past |
| David Soergel Other companies: Madrigal Pharmaceuticals, Inc. (Chief Medical Officer · Since at least Apr 21, 2025) | Sr. VP,Clinical Dev. & CMO · Jan 30, 2014 – Mar 2, 2017 · Past |
| John M Limongelli Other companies: Neos Therapeutics Inc (SVP & General Counsel · Mar 20, 2019 – Mar 19, 2021 · Past) | Sr. VP,General Counsel & CAO · Feb 28, 2018 – Feb 28, 2018 · Past |
| Marvin Johnson Other companies: Marinus Pharmaceuticals Inc (Director · Apr 17, 2023 – Feb 7, 2025 · Past) | Director · Mar 18, 2021 – Jun 13, 2024 · Past |
| Barbara Yanni | Chair of Compensation Committee · Since at least Nov 5, 2026 |
| Carrie L. Bourdow | President and Chief Executive Officer · Since at least Nov 5, 2026 |
| David Geoghegan | Sr. VP, Operations · Jan 29, 2018 – Feb 28, 2018 · Past |
| Jake R. Nunn | Member of the Nominating and Corporate Governance Committee · Since at least Nov 5, 2026 |
| Katrine Sutton | VP, Finance · Nov 26, 2024 – Nov 26, 2024 · Past |
| Leon O. Moulder | Chairman of the Board · Since at least Nov 5, 2026 |
| Mark Demitrack | Acting CMO · Dec 2, 2023 – Oct 8, 2024 · Past |
| Michael R. Dougherty | Executive Chairman · Since at least Nov 5, 2026 |
| Patricia M Drake | SVP, Chief Commercial Officer · Nov 10, 2022 – Dec 14, 2023 · Past |
| Robert Prachar | Sr. VP, Corp. Strategy · Mar 31, 2014 – Mar 31, 2014 · Past |
| Robert Yoder | Senior Vice President and Chief Business Officer · Since at least Nov 5, 2026 |
| Scott Applebaum | Corporate Secretary · Since at least Nov 5, 2026 |
| Scott Braunstein | Operating Partner at Aisling Capital Management LP · Since at least Nov 5, 2026 |